本頁面由Tiger Trade Technology Pte. Ltd.提供服務

Kiora Pharmaceuticals

2.76
+0.09003.37%
盤後2.760.00000.00%16:10 EDT
成交量:4.93萬
成交額:13.54萬
市值:1,223.34萬
市盈率:-1.15
高:2.85
開:2.63
低:2.63
收:2.67
52周最高:2.95
52周最低:1.76
股本:443.24萬
流通股本:385.25萬
量比:2.53
換手率:1.28%
股息:- -
股息率:- -
每股收益(TTM):-2.4100
每股收益(LYR):-2.6400
淨資產收益率:-56.36%
總資產收益率:-21.92%
市淨率:0.73
市盈率(LYR):-1.05

資料載入中...

2022/08/01

超過5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2022/07/28

超過5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2022/07/26

重要事件披露

8-K - Current report
2022/07/21

SEC問詢函

CORRESP [Cover] - Correspondence
2022/07/21

[修訂]招股説明書

S-1/A [Amend] - General form for registration of securities under the Securities Act of 1933
2022/07/19

SEC問詢函

CORRESP [Cover] - Correspondence
2022/07/19

[修訂]招股説明書

S-1/A [Amend] - General form for registration of securities under the Securities Act of 1933
2022/07/14

[補充]招股説明書

FWP - Filing under Securities Act Rules 163/433 of free writing prospectuses
2022/07/13

[修訂]招股説明書

S-1/A [Amend] - General form for registration of securities under the Securities Act of 1933
2022/07/08

季度報告

10-Q - Quarterly report [Sections 13 or 15(d)]
2022/07/07

[修訂]年度報告

10-K/A [Amend] - Annual report [Section 13 and 15(d), not S-K Item 405]
2022/06/21

重要事件披露

8-K - Current report
2022/05/31

重要事件披露

8-K - Current report
2022/05/23

重要事件披露

8-K - Current report
2022/05/03

員工持股計劃

S-8 - Securities to be offered to employees in employee benefit plans
2022/05/03

招股説明書

S-1 - General form for registration of securities under the Securities Act of 1933
2022/04/26

重要事件披露

8-K - Current report
2022/04/15

年度報告

10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2022/03/23

重要事件披露

8-K - Current report
2022/02/28

重要事件披露

8-K - Current report